tm logo

Monitor this mark

View On USPTO

TESTO-200
Live/Registered
REGISTERED

on 24 Dec 2024

Last Applicant/ Owned by

Advanced Pharmaceutical Technology, Inc.

132 South Central Avenue

Elmsford

NY

10523

Serial Number

98279841 filed on 21st Nov 2023

Registration Number

7619411 registered on 24th Dec 2024

in the Principal Register

Correspondent Address

Danielle DeFilippis

DANIELLE DEFILIPPIS NORRIS MCLAUGHLIN P.A.

NEW YORK, NY 10036

UNITED STATES

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

TESTO-200

injectable pharmaceutical preparations containing testosterone for the treatment of medical conditions, namely, testosterone deficiency, low testosterone and hypogonadism.

Classification Information

Class [005]
Pharmaceutical Products

injectable pharmaceutical preparations containing testosterone for the treatment of medical conditions, namely, testosterone deficiency, low testosterone and hypogonadism.

First Use Date in General

03rd Nov 2023

First Use Date in Commerce

03rd Nov 2023

Mark Details

Serial Number

No 98279841

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
24th Dec 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
24th Dec 2024REGISTERED-PRINCIPAL REGISTER
05th Nov 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05th Nov 2024PUBLISHED FOR OPPOSITION
16th Oct 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
26th Sep 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26th Sep 2024EXAMINER'S AMENDMENT ENTERED
26th Sep 2024EXAMINERS AMENDMENT E-MAILED
26th Sep 2024EXAMINERS AMENDMENT -WRITTEN